BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 6248865)

  • 1. Regulation of ornithine decarboxylase activity by corticotropin in adrenocortical tumor cell clones: roles of cyclic AMP and cyclic AMP-dependent protein kinase.
    Kudlow JE; Rae PA; Gutmann NS; Schimmer BP; Burrow GN
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2767-71. PubMed ID: 6248865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in cyclic AMP-dependent protein kinase and corticotropin (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis.
    Rae PA; Gutmann NS; Tsao J; Schimmer BP
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1896-900. PubMed ID: 221910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of adrenal ornithine decarboxylase by adrenocorticotropic hormone and cyclic AMP.
    Richman R; Dobbins C; Voina S; Underwood L; Mahaffee D; Gitelman ; Van Wyk J; Ney RL
    J Clin Invest; 1973 Aug; 52(8):2007-15. PubMed ID: 4352578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of ACTH stimulation of adrenal ornithine decarboxylase activity.
    Levine JH; Nicholson WE; Peytremann A; Orth DN
    Endocrinology; 1975 Jul; 97(1):136-44. PubMed ID: 166825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine decarboxylase activities.
    Insel PA; Fenno J
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):862-5. PubMed ID: 204937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of cyclic nucleotide regulation in protein-kinase-defective adrenal cells through somatic cell fusion.
    Schimmer BP; Horney SJ; Williams SA; Aitchison WA; Doherty PJ
    J Cell Physiol; 1984 Dec; 121(3):483-9. PubMed ID: 6094598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclic AMP and protein kinase on the steroidogenic action of ACTH, prostaglandin E1 and dibutyryl cyclic AMP in normal adrenal cells and adrenal tumor cells from humans.
    Saez JM; Evain D; Gallet D
    J Cyclic Nucleotide Res; 1978 Aug; 4(4):311-21. PubMed ID: 214468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of mutant adrenocortical tumor cells resistant to cyclic nucleotides.
    Schimmer BP; Tsao J; Knapp M
    Mol Cell Endocrinol; 1977 Aug; 8(2):135-45. PubMed ID: 200506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses of Y1 adrenocortical tumor cells to o-nitrophenyl sulfenyl ACTH.
    Rae PA; Zinman H; Ramachandran J; Schimmer BP
    Mol Cell Endocrinol; 1980 Mar; 17(3):171-9. PubMed ID: 6245980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of methyl xanthine derivatives on cyclic AMP levels and ornithine decarboxylase activity of rat tissues.
    Byus CV; Russell DH
    Life Sci; 1974 Dec; 15(11):1991-7. PubMed ID: 4378102
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged induction of hepatic ornithine decarboxylase and its relation to cyclic adenosine 3':5'-monophosphate-dependent protein kinase activation after a single administration of diethylnitrosamine.
    Olson JW; Russell DH
    Cancer Res; 1979 Aug; 39(8):3074-9. PubMed ID: 222443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The causal relationship between mutations in cAMP-dependent protein kinase and the loss of adrenocorticotropin-regulated adrenocortical functions.
    Wong M; Krolczyk AJ; Schimmer BP
    Mol Endocrinol; 1992 Oct; 6(10):1614-24. PubMed ID: 1333050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of cAMP and cAMP-dependent protein kinase in forskolin's actions on Y1 adrenocortical tumor cells.
    Schimmer BP; Schulz P
    Endocr Res; 1985; 11(3-4):199-209. PubMed ID: 3009170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
    Combest WL; Russell DH
    Mol Pharmacol; 1983 May; 23(3):641-7. PubMed ID: 6306431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP-dependent protein kinase controls basal gene activity and steroidogenesis in Y1 adrenal tumor cells.
    Clegg CH; Abrahamsen MS; Degen JL; Morris DR; McKnight GS
    Biochemistry; 1992 Apr; 31(14):3720-6. PubMed ID: 1567825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ornithine decarboxylase activity in rat ovarian cells in vitro.
    Piik K; Pösö H; Jänne J
    Endocr Res Commun; 1979; 6(2):107-21. PubMed ID: 228925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of cAMP and cAMP-dependent protein kinase in the regulation of adrenocortical functions: analysis using DNA-mediated gene transfer.
    Wong M; O'Brien D; Schimmer BP
    Biochem Cell Biol; 1986 Nov; 64(11):1066-71. PubMed ID: 3030365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ACTH on ornithine decarboxylase activity of adrenal medulla and cortex.
    Almazan G; Pacheco P; Sourkes TL
    Biochem Pharmacol; 1983 Mar; 32(5):932-3. PubMed ID: 6301506
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of adenosine and guanosine on thyroidal ornithine decarboxylase, protein kinase, and the adenosine 3',5'-monophosphate-adenylate cyclase system in the mouse.
    Friedman Y; Levasseur S; Crowell D; Burke G
    Endocrinology; 1981 Jul; 109(1):113-9. PubMed ID: 6263580
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of cyclic AMP-dependent protein kinase(s) by growth hormone in the liver and adrenal gland of the rat.
    Byus CV; Haddox MK; Russell DH
    J Cyclic Nucleotide Res; 1978 Feb; 4(1):45-54. PubMed ID: 205562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.